These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 21884980)
1. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. Lee ST; Li Z; Wu Z; Aau M; Guan P; Karuturi RK; Liou YC; Yu Q Mol Cell; 2011 Sep; 43(5):798-810. PubMed ID: 21884980 [TBL] [Abstract][Full Text] [Related]
2. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Shi B; Liang J; Yang X; Wang Y; Zhao Y; Wu H; Sun L; Zhang Y; Chen Y; Li R; Zhang Y; Hong M; Shang Y Mol Cell Biol; 2007 Jul; 27(14):5105-19. PubMed ID: 17502350 [TBL] [Abstract][Full Text] [Related]
3. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. Sun F; Chan E; Wu Z; Yang X; Marquez VE; Yu Q Mol Cancer Ther; 2009 Dec; 8(12):3191-202. PubMed ID: 19934278 [TBL] [Abstract][Full Text] [Related]
4. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer. Wu J; Crowe DL Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860 [TBL] [Abstract][Full Text] [Related]
5. Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer. Lawrence CL; Baldwin AS PLoS One; 2016; 11(10):e0165005. PubMed ID: 27764181 [TBL] [Abstract][Full Text] [Related]
6. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor. Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341 [TBL] [Abstract][Full Text] [Related]
7. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140 [TBL] [Abstract][Full Text] [Related]
8. Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells. Ennen M; Minig V; Grandemange S; Touche N; Merlin JL; Besancenot V; Brunner E; Domenjoud L; Becuwe P Free Radic Biol Med; 2011 Jun; 50(12):1771-9. PubMed ID: 21419216 [TBL] [Abstract][Full Text] [Related]
9. EZH2 promotes a bi-lineage identity in basal-like breast cancer cells. Granit RZ; Gabai Y; Hadar T; Karamansha Y; Liberman L; Waldhorn I; Gat-Viks I; Regev A; Maly B; Darash-Yahana M; Peretz T; Ben-Porath I Oncogene; 2013 Aug; 32(33):3886-95. PubMed ID: 22986524 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer. Reijm EA; Jansen MP; Ruigrok-Ritstier K; van Staveren IL; Look MP; van Gelder ME; Sieuwerts AM; Sleijfer S; Foekens JA; Berns EM Breast Cancer Res Treat; 2011 Jan; 125(2):387-94. PubMed ID: 20306127 [TBL] [Abstract][Full Text] [Related]
11. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements. Tonini T; D'Andrilli G; Fucito A; Gaspa L; Bagella L J Cell Physiol; 2008 Feb; 214(2):295-300. PubMed ID: 17786943 [TBL] [Abstract][Full Text] [Related]
12. MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes. Fujii S; Tokita K; Wada N; Ito K; Yamauchi C; Ito Y; Ochiai A Oncogene; 2011 Sep; 30(39):4118-28. PubMed ID: 21499305 [TBL] [Abstract][Full Text] [Related]
13. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. Tsang DP; Cheng AS J Gastroenterol Hepatol; 2011 Jan; 26(1):19-27. PubMed ID: 21175789 [TBL] [Abstract][Full Text] [Related]
15. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers. De Brot M; Rocha RM; Soares FA; Gobbi H Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57 Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143 [TBL] [Abstract][Full Text] [Related]
19. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513 [TBL] [Abstract][Full Text] [Related]
20. EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer. Kaur P; Verma S; Kushwaha PP; Gupta S Cancer Lett; 2023 Apr; 560():216143. PubMed ID: 36958695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]